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Abstract
Background To investigate long-term intraocular pressure
(IOP) changes after vitrectomy for epiretinal membrane
(ERM) or macular hole (MH).
Methods We retrospectively reviewed the medical records of
57 eyes with ERM and 61 eyes with MH that underwent
vitrectomy. IOP levels and changes at 1, 3, 6, 12 months,
and the final visit from baseline were evaluated in
vitrectomized eyes and non-vitrectomized fellow eyes.
Results In the ERM group, the mean follow-up period was
29.3 months; the mean preoperative IOP in the operated eyes
was 12.9±2.5 mmHg and the final IOP was 13.2±2.9 mmHg.
In the MH group, the mean follow-up period was 25.6 months;
the mean preoperative IOP in the operated eyes was 13.3±
2.5 mmHg and the final IOP was 14.0±3.2 mmHg. The mean
final IOP of the fellow unoperated eyes was 13.0±2.5mmHg in
the ERM group and it was 12.9±3.2 mmHg in the MH group.
A significant difference was found between the operated eyes
and fellow eyes at the final visit in the MH group (P <0.01) but
not in the ERMgroup (P =0.40).MHgroupwas significantly at
high risk of IOP increase after vitrectomy (P <0.01).
Conclusions IOP increase after vitrectomywas found in some
eyes with MH during long-term follow-up but it was unlikely
in eyes with ERM.
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Introduction
Transient increases in intraocular pressure (IOP) after pars
plana vitrectomy due to inflammation, silicone oil tamponade,
residual viscoelastic substance, and expansile gas filling are
well-known early postoperative complications [1–6]. Howev-
er, a few previous studies have reported late development of
open-angle glaucoma (OAG) after vitrectomy [7–10].
Chang firstly suggested the development and worsening of
OAG in patients who underwent vitrectomy in 2006 [7]. Luk
et al. also reported the risk of OAG after vitrectomy in patients
with epiretinal membrane (ERM) and idiopathic macular hole
(MH) [8]. In contrast, Yu et al. reported that OAG does not
develop after vitrectomy in patients with ERM, MH, and
retinal detachment [9]. Lalezary et al. also reported that
OAG does not develop after vitrectomy in patients with dia-
betes and vitreous hemorrhage, ERM, or MH [10].
These reports included various diseases, IOP measurement
methods, and diagnostic criteria for OAG. In addition, the
presence of diabetes might complicate this issue because of
the potential for a decreased risk of OAG modified by retinal
hypoxia [11, 12]. Vitrectomy for ERM is considered to be the
least clinically invasive among the various vitrectomy proce-
dures; therefore, a simple comparison between ERMand other
vitreoretinal diseases for vitrectomy might reveal further
mechanism of late-onset OAG. We performed a retrospective
study to evaluate IOP changes after vitrectomy in eyes with
ERM and MH including naive fellow eyes to evaluate the
effect of the surgery on IOP changes.
Patients and methods
We conducted a retrospective review of the medical records of
190 patients with ERM and 157 patients with MH who
underwent surgery performed by two surgeons (MO, HK)
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from May 2005 through November 2009. A three-port pars
plana vitrectomy using a 20, 23, or 25-gauge system under
retrobulbar anesthesia was performed using the ACCURUS
vitrectomy system (Alcon, Ft. Worth, TX). Simultaneous or
two-stage cataract surgery (phacoemulsification and aspira-
tion) was performed if needed. Postoperatively, steroidal eye
drops (betamethasone 0.1 % eye drops) were instilled for 1–
2 weeks followed by fluorometholone 0.1 % for several
weeks.
The inclusion criteria were a treatment-naive ERM or MH
and at least a 12-month follow-up period including examina-
tions at 1, 3, 6, and 12 months after vitrectomy. The exclusion
criteria were a preoperative diagnosis of glaucoma or ocular
hypertension (OHT); diabetes with or without diabetic reti-
nopathy; and a history of vitrectomy, penetrating ocular trau-
ma, ocular inflammation, ocular ischemia, or therapy with a
long-term topical steroid medication. These criteria also ap-
plied to the fellow eyes. We also evaluated the preoperative
lens status (phakia, pseudophakia, or aphakia) and the use of
intraoperative adjuvant drugs such as triamcinolone acetonide
to visualize the vitreous body or for membrane peeling and
indocyanine green (ICG) stain to visualize the internal limit-
ing membrane (ILM). After a fluid-gas exchange using 20 %
sulfur hexafluoride expansile gas, patients who underwent
surgery for an MH were instructed to maintain a face-down
position for 1 week postoperatively.
The IOP was measured three times at preoperative exami-
nation and follow-up visits after vitrectomy using a non-
contact tonometer in the operated eye and fellow eye of each
patient. Three IOP values were averaged and analyzed between
baseline and each postoperative visit at 1, 3, 6, 12 months and
the final visit. We defined IOP increase of 4 mmHg as a cutoff
point because the mean diurnal fluctuation is 3.7 mmHg in
normal eyes without glaucoma [13]. The best-corrected visual
acuity (VA) was measured using a Landolt C chart test, and the
value was converted to the logarithm of the minimum angle of
resolution (logMAR). Statistical analyses were performed
using GraphPad Prism 6 software (GraphPad Software Inc.,
La Jolla, CA) and JMP 10 software (SAS Institute Inc., Cary,
NC). Student’s unpaired and paired t-tests were used to com-
pare two groups of normally distributed independent and
matched groups, respectively. Mann–Whitney’s U and
Wilcoxon signed-rank tests were used to compare two groups
of independent and matched groups without normal distribu-
tion, respectively. Multivariate analysis and Kaplan–Meier
survival analysis with log-rank test were also performed. Data
are expressed as the mean ± standard deviation; P values less
than 0.05 were considered significant.
Results
A total of 57 eyes with ERM and 61 eyes with MH met the
inclusion criteria. The mean follow-up period was 29.3±
15.7 months (range, 12–61.3) in the ERM group and 25.6±
14.1 months (12–57.7) in the MH group.
Table 1 shows the baseline demographics of the current
study. There was no difference in the follow-up periods,
gender distribution, or patient ages between the two groups.
There was a significant difference in the preoperative
logMARVA (P <0.0001).
Table 2 shows the surgical details. There was no difference
between the two groups in the preoperative and postoperative
lens status regarding the presence of the crystalline lens. The
rates of intraoperative adjunctive procedures including use of
triamcinolone acetonide, ICG, and ILM peeling were signifi-
cantly higher in the MH group than in the ERM group (P <
0.0001, respectively).
In the ERM group, the mean preoperative IOP of the
operated eyes was 12.9±2.5 mmHg (range, 8.3–18.5) and
the mean IOP at the final visit was 13.2±2.9 mmHg (range,
8.0–19.0). Those in the fellow eyes were 13.1±2.5 mmHg
(range, 8.0–18.3), and 13.0±2.5 mmHg (range, 8.5–19.3),
respectively. No difference was found between the operated
eyes and fellow eyes at baseline (paired t -test, P =0.64) and it
remained insignificant to the final visit (paired t -test, P =0.40)
(Fig. 1).
In the MH group, the mean preoperative IOP in the oper-
ated eyes was 13.3±2.4 mmHg (8.0–18.7) and the mean IOP
at the final visit was 14.0±3.2 mmHg (6.3–21.7). Those in the
fellow eyes were 13.3±2.5 mmHg (8.3–19.0), and 12.9±
3.2 mmHg (6.7–24.0), respectively. No difference was found
between the operated eyes and fellow eyes at baseline (paired
t -test, P =0.89), however, the IOP only at the final visit in the
operated eyes was significantly higher than fellow eyes in the
MH group (paired t-test, P <0.01) (Fig. 2).
Table 1 The baseline demo-
graphics of epiretinal membrane




Operation date 2005.5–2009.11 2004.12–2009.11 –
Follow up period, months (range) 29.3±15.7 (12–61.3) 25.6±14.1 (12–57.7) 0.19
Male/female 15 (26 %)/42 (74 %) 20 (33 %)/41 (67 %) 0.55
Age, years 66.0±9.4 (32–84) 65.1±7.3 (44–82) 0.36
Best corrected visual acuity (logMAR) 0.294±0.171 0.708±0.311 < 0.0001
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Table 3 shows the proportions of IOP increases by 4mmHg
or greater compared with baseline. At the final visit, the IOP
increased and sustained by 4 mmHg or more from baseline in
4 (7.0 %) operated eyes and 4 (7.0 %) fellow eyes in the ERM
group (P =1.00) and 10 (8.2 %) operated eyes and 7 (4.9 %)
fellow eyes in the MH group (P =0.60). No significant differ-
ences were found between the two groups in the prevalence of
IOP increases in the operated eyes at final visit (P =0.16). IOP
changes were statistically insignificant at any follow up period
between eyes operated with and without TA.
We defined as the death event when the IOP increased by
4 mmHg or greater than baseline in operated eyes and
performed Kaplan–Meier survival analysis. The operated eyes
in MH group showed statistically significantly higher risk of
IOP increase than those in ERM group by log-rank test (P <
0.01) (Fig. 3). Multivariate analysis revealed that age and
baseline IOP alone significantly affected for the IOP value
of operated eyes at final visit but not in disease. (Table 4)
During the follow-up period, no eye was diagnosed with
glaucoma or treated with antiglaucoma drugs.
Discussion
The first report about late-onset OAG was by Chang in 2006,
in which he suggested the development and worsening of
OAG in patients who underwent vitrectomy and found that
the mean IOP increased significantly in operated eyes com-
pared with fellow eyes, especially in pseudophakic and
aphakic eyes [7]. He suggested that the incidence of OAG
after vitrectomy might increase to 15–20 % and that the
pathogenesis was assumed to be increased partial pressure of
oxygen in the vitreous cavity after vitrectomy that might cause
oxidative stress on the trabecular meshwork in the anterior
chamber, particularly in the absence of a crystalline lens. Luk
et al. also reported the risk of OAG after vitrectomy in patients
with an epiretinal membrane (ERM) and idiopathic macular
hole (MH) [8]. Those investigators reported that the incidence
of late-onset OAG was 7.9 % in vitrectomized eyes and that
13 % of pseudophakic eyes developed OAG; the incidence in
phakic eyes was 2 %. The authors concluded that the crystal-
line lens might protect against late development of OAG after
vitrectomy.
In contrast, Yu et al. and Lalezary et al. reported that OAG
does not develop after vitrectomy. Yu et al. mainly analyzed
patients with ERM,MH, and retinal detachment. They report-
ed the prevalence rates of OAG and ocular hypertension were
4.31 % and 4.31 % in vitrectomized eyes and 2.49 % and
2.95 % in fellow eyes. The study concluded that vitrectomy
was safe and did not increase the risk of OAG [9]. More
recently, Lalezary et al. evaluated IOP after vitrectomy in
patients with diabetes and vitreous hemorrhage, ERM, or






ERM epiretinal membrane; MH
macular hole
TA triamcinolone acetonide; ICG
indocyanine green; ILM internal
limiting membrane
ERM MH P
n=57 (48.3 %) n=61 (51.7 %)
Preoperative lens status Pseudophakia 7 (12.3 %) 2 (3.2 %) 0.19a
Aphakia 0 (0.0 %) 1 (1.6 %)
Cataract surgery Combined PEA+IOL 46 (80.7 %) 57 (93.4 %) 0.61b
Two-staged PEA+IOL 2 (3.5 %) 0 (0.0 %)
Lens spared 2 (3.5 %) 1 (1.6 %)
Adjunctive procedure TA visualization 21 (36.8 %) 50 (82.0 %) < 0.0001
ICG staining 3 (5.3 %) 51 (83.6 %) < 0.0001
ILM peeling 9 (15.8 %) 61 (100.0 %) < 0.0001
Fig. 1 Intraocular pressures (IOP) of operated eyes for epiretinal mem-
brane (ERM) and fellow eyes. No difference was found between the
operated eyes and fellow eyes at the final visit (P=0.40)
Fig. 2 Intraocular pressures (IOP) of operated eyes for macular hole
(MH) and fellow eyes. The IOP at the final visit in the operated eyes
(asterisk) was significantly higher than fellow eyes (P<0.01)
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MH and reported that the incidence of increased IOP levels
exceeding 4 mmHgwas not significant between operated eyes
(15 %) and fellow eyes (14 %). They concluded that the IOP
does not increase after vitrectomy even after removal of the
crystalline lens [10].
The four studies mentioned previously included various
diseases, IOP measurement methods, and diagnostic criteria
for OAG. In addition, the presence of diabetes might compli-
cate this issue because of the potential for a decreased risk of
OAG modified by retinal hypoxia [11, 12]. Vitrectomy for
ERM is considered to be the least clinically invasive among
the various vitrectomy procedures; therefore, a simple com-
parison between ERM and other vitreoretinal diseases for
vitrectomy might shed light on the further mechanism of
late-onset OAG.
When we compared the IOP values between the operated
eyes and fellow eyes in the current study, we found no signif-
icant difference in the ERM group throughout the study peri-
od; however, we found a significant difference at the final visit
in the MH group. Furthermore, the mean IOP increase in the
operated eyes in the MH group was 0.7 mmHg, which was
markedly higher than that of 0.3 mmHg in ERM group. This
difference suggests the potential risk of IOP increases and
developing late-onset OAG in the MH group. It is difficult
to define a clear criterion for diagnosis of late-onset OAG.
Hence, we excluded patients with diabetes who might be
affected by relative ocular hypoxia and obtained the time
series graph of the IOP levels from preoperatively to the final
visit. As a result, no eye was treated for OAG after vitrectomy
throughout the follow-up period because the follow-up period
might have been too short for late-onset OAG to develop.
However, the upward trend and significant increase in IOP
found in the MH group was notable.
The ever-increasing IOP changes in operated eyes in the
MH group might to some extent be due to oxidation and
alteration of the trabecular meshwork as previously reported
because almost all eyes were underwent cataract surgery with
vitrectomy [7]. However, we did not see IOP increases in the
ERMgroup, although the postoperative lens status was similar
between the ERM and MH groups in the current study.
The effects of residual TA should be taken into consider-
ation. In the current study, TAwas cleared intraoperatively as
much as possible and IOP changes had shown trends to
decrease rather than increase especially at 1 month after treat-
ment. It was reported that intravitreal TA was cleared within
30 days to undetectable levels in vitrectomized rabbit eyes.
Hence, the usage of TA as an adjunctive agent might not affect
the IOP levels in long-term [14].
Therefore, we hypothesized that a difference in the postop-
erative inflammatory stress or the physical effect between the
ERM and MH surgeries increased the concentrations of in-
flammatory cytokines or caused clogging of the trabecular
meshwork with intraoperative sludge after fluid–gas exchange.
The face-down position also could have been a potential cause.
Multivariate analysis revealed that significant risk factors
were not so much gas tamponade, vitrectomy system, or
Table 3 The proportions of the intraocular pressure (IOP) increases
4 mmHg or greater compared with baseline
12 M Final
ERM operated n=57 3 (5.3 %) 4 (7.0 %)
ERM fellow n=57 0 (0.0 %) 4 (7.0 %)
MH operated n=61 5 (3.3 %) 10 (8.2 %)
MH fellow n=61 1 (3.3 %) 7 (4.9 %)
Fig. 3 The Kaplan–Meier survival curves in operated eyes for epiretinal
membrane (ERM) (solid line) and macular hole (MH) (dashed line) with
postoperative intraocular pressure by 4 mmHg or greater from baseline.
MH had significantly at high risk of IOP increase after vitrectomy (P<
0.01 by log-rank test)
Table 4 Multiple linear regression analysis to investigate the risk factors
affecting postoperative IOP changes
Variable β* P
Disease (ERM) −0.16 0.4
Gender (female) −0.04 0.67
Age −0.36 < 0.001
Lens status (aphakia) −0.2 0.34
Lens status (combined) 0.09 0.58
Lens status (lens spared) −0.12 0.43
System (20 gauge) 0.02 0.89
System (23 gauge) −0.16 0.15
TA (−) −0.06 0.57
ICG (−) −0.11 0.43
ILM peeling (−) 0.21 0.24
Baseline IOP −0.29 < 0.01
* Standardized coefficient; ERM epiretinal membrane; TA triamcinolone
acetonide
ICG indocyanine green; ILM internal limiting membrane; IOP intraoc-
ular pressure
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adjunctive procedures but age and baseline IOP alone. On the
other hand, Kaplan–Meier survival analysis with log-rank test
between ERM andMH showed that the eyes inMH group had
a higher risk of IOP increase than those in ERM group, and
thus gas tamponade could have a possibility of IOP increase in
long-tem. Recently, Ki-I et al. reported about long-term IOP
changes after combined cataract surgery and vitrectomy in
ERM or MH [15]. In their report, gas tamponade was not
affected postoperative IOP and they concluded that the IOP
change after phacovitrectomy may be limited and some case
showed IOP increase exceeding baseline or fellow eyes in
long-term, but they did not performed multivariate analysis.
Our results were consistent with the report by Ki-I et al. at a
point. It is inadequate for a definitive conclusion from these
results because one possible reason could be refractive errors
or axial lengths as the risk factors of open-angle glaucoma. It
is well known that high myopia is one of the risk factors of
OAG [16–18]. Further investigation is warranted with adjust-
ed comorbid risk factors of OAG.
Our observations should be confirmed by further studies,
because the current sample sizes were small, the study was
retrospective, and the IOP was not measured using Goldmann
applanation tonometry but non-contact tonometer, which
could be affected by the corneal thickness. However, the
IOP levels measured with non-contact tonometer are adopt-
able when the IOP levels are normotensive [19].
In conclusion, the current data suggested the risk of in-
creasing IOP and possible development of late-onset OAG
after MH surgery with gas tamponade. A new study with
standardized IOP measurements, adjusted refractive errors,
years of follow-up, a larger number of participants, and uni-
form definitions of glaucoma of OAG and OHTare needed to
confirm this issue. Physicians should be aware of the potential
risk of increased IOP after vitrectomy and provide treatment
before irreversible visual impairment develops.
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